Phendimetrazine Tartrate
Product Images NDC 10544-041

3 FDA label images from Blenheim Pharmacal, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Phendimetrazine Tartrate (NDC 10544-041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (3e594fab Figure 01)

Structure (3e594fab Figure 01)
Chemical structure of Phendimetrazine Tartrate, showing the molecular arrangement of the active ingredient and tartrate salt components.*
FDA Label Image

Kvk (Tech)

FDA Label Image

35mg 30ct (Label Phendimetrazine Tartrate Tabs 35mg Bpi(10544 041 30) Kvk Tech(10702 077 10) Rev1)

35mg 30ct (Label Phendimetrazine Tartrate Tabs 35mg Bpi(10544 041 30) Kvk Tech(10702 077 10) Rev1)
The image shows a prescription label for Phendimetrazine Tartrate Tablets, USP 35 mg, containing 30 tablets. It includes dosage and storage instructions, manufacturing details by KVK Tech, Inc., and repackaging information by Blenheim Pharmacal, Inc. The label displays the NDC number 10544-041-30, a caution about federal law prohibiting transfer of the drug, and notes the medication is for Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.